1 / 58

Obstructive Jaundice – Whipple’s Operation Anesthetic Management

Obstructive Jaundice – Whipple’s Operation Anesthetic Management. Munisha Agarwal Professor Deptt. of Anaesthesiology & Intensive Care L N Hospital & Maulana Azad Medical College Delhi. www.anaesthesia.co.in anaesthesia.co.in@gmail.com. Obstructive Jaundice.

alda
Download Presentation

Obstructive Jaundice – Whipple’s Operation Anesthetic Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Obstructive Jaundice – Whipple’s OperationAnesthetic Management Munisha Agarwal Professor Deptt. of Anaesthesiology & Intensive Care L N Hospital & Maulana Azad Medical College Delhi Obs. J www.anaesthesia.co.inanaesthesia.co.in@gmail.com

  2. Obstructive Jaundice Physiological functions of Liver ? Obs. J

  3. Physiological functions of Liver • Glucose Homeostasis • Fat Metabolism • Protein Synthesis • Drug & Hormone Metabolism • Bilirubin formation &excretion • Anti bacterial action • Blood Reservoir Obst. J

  4. Glucose homeostasis Glucose hepatocytes glycogen glucose lactate glycerol AA Obst. J

  5. Glucose Homeostasis • Glycogen stores 75gm 24—48hrs • Anesthesia – gluconeogenesis • Provide ext. source of glucose Obst. J

  6. Fat metabolism • Synthesis of lipo-proteins & cholesterol • Oxidation of FA to ketone bodies Obst. J

  7. Protein Metabolism • Deamination of AA • Formation of urea • Plasma proteins - All except y globulin & factor VIII - Albumin daily prod. 10—15g/d (3.5-5.5gm%) - liver disease  alb  glob Albumin ? Obst. J

  8. Protein synthesis • Plasma O. P. • Drug binding • Coagulation • Hydrolysis Obst. J

  9. Drug binding • Drugs reversibly combine with Albumin •  albumin  binding sites  free drug • Albumin < 2.5gm% • Acute Hepatic dysfunction ? Coagulation ? Obst. J

  10. Drug binding • Acute hepatic dysfunction - drug binding not affected • T ½ Albumin : 14 – 21 days • Coagulation : affected (2—6hrs) • Vitamin K dependent Coag. Factors? Obst. J

  11. Coagulation • Prothrombin, fibrinogen • Factor V, VII, IX, X ( except VIII) Deranged Coagulation ? Obst. J

  12. Coagulation Deranged coagulation • ed synthesis of Clotting factors • ed PT Vit. K deficiency d/t biliary obstruction absence of bile salts • Thrombocytopenia • ed Fibrinolysins Obst. J

  13. Coagulation • Evaluate PT/ PTTK/ BT • LFT grossly deranged before coagulation abnormalities appear • 20%--30% activity required for normal coagulation • T1/2 of clotting factors produced in liver is very short (in hrs) • Ac. Hep dysfunction  Coag. Abn. Obst. J

  14. Drug metabolism - Lipophilic →water soluble, less reactive Enzymatic reaction phase I - oxidation (Cyt P450) - reduction & hydrolysis (L.A) phase II - conjugation, glucuronidation, sulphation, methylation & acetylation - UDGT ( Bilirubin, morphine, aminophylline) Conjugation reaction? Obst. J

  15. Drug metabolism Clearance of drugs from plasma High HE ratio ~ Hepatic Blood Flow (HBF) Lidocain, Pethidine, Fentanyl low HE ratio ~microsomal enzymes ~protein binding diazepam, thiop, pancuronium Obst. J

  16. Drug metabolism Anesthetic implications • Chronic liver disease  drug metabolism d/t - ed no. of hepatocytes - HBF • Repeated injection  cumulative effect • Volatile anesth. Agents  ed clearance of drugs Obst. J

  17. Bilirubin formation & excretion • Daily prod 250—350mg/d • Interpretation of plasma & urine bilirubin • Categories of liver dysfunction 1 unit BT ? Obst. J

  18. Blood Reservoir • 10% of total blood volume • Available for Auto transfusion into central circulation Obst. J

  19. Hepatic Blood Supply • Unique ? Obst. J

  20. Hepatic Blood Supply • 25% to 30% of CO • Dual supply Portal V (75%) 85% saturated Hepatic A (25%) 95%saturated 2/3 of oxygen used by liver Obst. J

  21. Control of Liver Blood Flow INTRINSIC • AUTOREGULATION - Hepatic artery-80 mmHg - Portal vein – flow from spleen, intestine - resistance to vascular bed • Hepatic Arterial Buffer response. Extrinsic ? Obst. J

  22. Increase HBF Acute hepatitis Supine posture Hypercapnia Drugs βadrenostimulation Decrease HBF Hypoxia Hepatic cirrhosis Upright posture Hypocapnia/IPPV/PEEP Drugs βadrenoreceptor blockade/ α agonist Ganglion blockade Anaesthetic agent Control of Liver Blood FlowEXTRINSIC Obst. J

  23. Liver Function Tests • Non specific • Large hepatic reserve LFT ? Obst. J

  24. Liver Function Tests • S. Bilirubin (T) - 0.3—1.1mg% {(I) 0.2-0.7mg%, (D)0.1—0.4mg%) • Transaminases—SGOT/SGPT/LDH hepatocyte damage hypoxia/drugs/viruses Extrahepatic—heart/lungs/skeletal ms Marked (3x)-ac. Hep damage • Alkaline phoshphatase - bile duct cells slight obstruction (3x) bone –extrahep source • S. Albumin • 5- Nucleotidase • GGT Prehepatic / Hepatic / Posthepatic J ? Obst. J

  25. Obst. J

  26. SPECTRUM OF LIVER DISEASE • Parenchymal-Acute & Chronic Hepatitis -Hepatic Cirrhosis (+ portal hypertension) • Cholestatic -Intrahepatic – viral hepatitis – drug induced -Extrahepatic (Obstructive jaundice) – Calculi, stricture, growth. Parenchymal disease ultimately possesses an obstructive component & Obstructive disease produces cellular dysfunction. Clinical Hallmarks ? Obst. J

  27. Signs &Symptoms • Prog sev jaundice • Dark urine • Clay coloured stools • Pruritis • High fever+ chills • Biochemical hallmarks Obst. J

  28. Obstructive Jaundice • Primary mechanism- Obst. of E.H. bile duct. • Bile duct pressure - Normal – 10-15 cm H2O > 15 cm → bile flow decreases > 30 cm → bile flow stops Obst. J

  29. Pathophysiological consequences Obst. J Bile Acids are potent toxins

  30. Endotoxemia in obstructive jaundice Bile salts are surfactants----disrupt endotoxins Causes of endotoxemia • Absence of bile in intestine  intest.bact. Flora • Breakdown of GI mucos. barrier- bact. translocation • Hepatic RES function clearance of endotoxins Systemic Alterations – CVS ? Obst. J

  31. Systemic alterations • Circulatory homeostasis CHOLEMIA ●vasodepressor effect on BVs ● cardiodepressor  LVF ● PVR   BP  sympath + renal & cerebral vasoconstriction ●redistribution of TBV  trapping of blood in splanc. Circulation  effective BV ● NO - insensitive to vasoconstrictors  Hypotension & circulatory collapse Obst. J

  32. Renal system • Mild renal vasoconstriction • Renal hypoperfusion( hypovolemia) • Refractoriness of tubules to ADH • Endotoxemia Obst. J

  33. Renal System • Acute Renal Failure • Hepatorenal Syndrome Obst. J

  34. Renal system Hepatorenal Syndrome • Oliguria • Inability to excrete Na in urine( 10mmol/l) • Functional change • Normal renal blood flow • Treatment : Prevention-identify high risk patients Obst. J

  35. Systemic alterations • Coagulopathy(low grade DIC) Impaired platelet function  FDP---inhibition of fibrinolysis  Endotoxins • Hm gastritis & stress ulcers • Impaired wound healing Obst. J

  36. Anesthetic problems in Obstructive Jaundice ? Obst. J

  37. PROBLEMS DUE TO DYSFUNCTION OF LIVER ITSELF : - Low serum proteins - Coagulopathy - Drug metabolism and disposition - Metabolic derangement - Hypoglycemia - Electrolyte imbalance - Haematological - Anaemia – Thrombocytopenia – Leucopenia – DIC - Deficiency of fat soluble vitamins (A, D, E, K) - Increased serum cholesterol (atheromatous changes) Obst. J

  38. PROBLEMS DUE TO INVOLVEMENT OF OTHERSYSTEMS • CVS– TBV , PVR , Circulatory collapse • Renal - pre renal azotemia - Hepatorenal failure • GIT - Hm gastritis & stress ulcers • Resp.– Arterial Hypoxemia - vulnerability to pulmonary infection • CNS – Hepatic encephalopathy Problems related to surgery ? Obst. J

  39. Problems related to surgery • Whipple’s procedure---Carc. Head of panc • Distal gastrectomy,PJ, HJ, GJ • Major surgery---long duration • Increased blood loss/fluid shifts • Wide incision---Roof top—warrants good postoperative analgesia • Extensive monitoring reqd for favourable outcome Obst. J

  40. Risk Factors • Age > 60yrs • Albumin < 30gm% • Preop. renal dysfunction • Long standing biliary obstruction  infection  sepsis • Weight loss Serum creatinine & Sepsis—prognostic factors Periop CVS collapse & renal failure Obst. J

  41. Preoperative Assessment OBJECTIVES • Assess the type and degree of liver dysfunction. • Assess effect on other system. • To ensure – post operative facilities (High risk patient). Obst. J

  42. Preoperative Assessment • History • Clinical examination • Investigations ??? Unexplained jaundice of 4wks duration or longer will prove to be caused by obstruction in nearly 75% patients Blumgart L Obst. J

  43. Preoperative Investigations To know the pattern of disease : ­ S. Bilirubin ­ SGOT, SGPT 90% predictive ­ alk. phosphatase Obst. J

  44. Preoperative Investigations To judge the synthetic ability of liver • Serum albumin– < 2·5 gm% - severe damage • Albumin/globulin ratio – reversed. • Prothrombin time –> 1·5 sec. Over control – INR - > 1.3 (D/D – Par entral Vit. K – Obst. Jaundice) Obst. J

  45. (i) Haematological · Hb TLC, DLC Platelet Count Clotting factors (PT, PTTK) BT (ii)Cardiorespiratory Chest X-ray ECG Blood gases (iii) Metabolic- Serum proteins Serum glucose Electrolyte Urea / Creatinine Urinary-Urea/ Creatinine -Electrolyte (iv) Hepatic imaging (v) Microbiological – - Culture -Hep. B marker - Viral antibodies To assess general condition of patient Obst. J

  46. Preoperative management • Avoid prolonged hyperbilirubinemia • Treat infection –cholangitis • Use Aminoglycosides carefully • Avoid pre renal failure • Correct Anaemia/Coagulation/hypoalbuminemia • Avoid all NSAIDS • I/V saline & mannitol pre & postop Obst. J

  47. Preoperative management No conclusive evidence for – • Preop percutaneous biliary drainage • Gut sterlization • Polymyxin B • Oral bile salts Pre medication ? Obst. J

  48. Premedication • Anxiolytic – oral short acting BDZ • Oral H2 antagonist • Vit. K (Obst. J) – 10 mg B D X 3 day • If Bilirubin > 8 mg% – · I/V fluid – 1-2 ml/kg/hr. · Mannitol – 100 ml of 20% 2 hrs preop. • Order morning PT / S. Electrolyte • Preop urinary catheter & CVP Obst. J

  49. Anaesthetic Management General Considerations Minimize physiological insult to liver & kidney • Maintain O2 supply – demand relationship in liver. →Adequate pulmonary ventilation and cardiovascular fn. • Maintain renal perfusion →Avoid Hypotension, hypoproteinemia & Hypoxia → meticulous fluid balance Choose appropriate anaesthetic agent Metabolism of drugs + Effect on HBF. Induction ? Obst. J

  50. Anesthetic technique • General anesthesia • Preoxygenation • Induction - Thiopentone Propofol • Muscle relaxant – Suxamethonium Vecuronium 0.15mg/kg Rocuronium0.6mg/kg Atracurium(DOC) • Opioids ? Obst. J

More Related